There were 7.0% of participants who got the placebo who had adverse reactions
during this study. This was 4 out of 57 participants.
None of the participants had serious adverse reactions during this study. None of
the participants stopped getting study treatment due to adverse reactions.
What serious adverse reactions happened during this study?
None of the participants had serious adverse reactions during this study.
What adverse reactions happened during this study?
There were 11.2% of participants who had adverse reactions during this study. This
was 13 out of 116 participants.
The most common adverse reaction was a rash at the injection site.
The table below shows the adverse reactions that happened in the participants
during the study. Some participants had more than 1 adverse reaction.
Adverse reactions
Tezepelumab Placebo
Adverse reaction
(out of 59 participants) (out of 57 participants)
Rash at the injection site 8.5% (5) 3.5% (2)
Itching at the injection site 6.8% (4) 1.8% (1)
Inflammation at the injection site 3.4% (2) 0.0% (0)
Headache 1.7% (1) 3.5% (2)
Too much fat in the liver 1.7% (1) 0.0% (0)
Fungal skin infection 1.7% (1) 0.0% (0)
Suddenly developing hives 1.7% (1) 0.0% (0)
Pain at the injection site 1.7% (1) 0.0% (0)
Skin bump at the injection site 1.7% (1) 0.0% (0)
Swelling at the injection site 1.7% (1) 0.0% (0)
10 | Clinical Study Results